Impact of HBAIC in type 2 diabetes mellitus in Mexico:: Simulation analysis, a pharmacoeconomic perspective

被引：0

作者：

Castañeda, R. C. L. ^{[1
]}

Sil, M. J. S. A. ^{[1
]}

Acevedo, G. A. R. ^{[1
]}

Manterola, S. O. M. C. ^{[2
]}

Ramirez, J. R. ^{[3
]}

Rios, L. R. N. ^{[3
]}

Romero, S. R. ^{[4
]}

Barquera, S. B. ^{[5
]}

机构：

[1] Hosp Carlos Mc Gregor Sanchez Navarro, IMSS, Mexico City, DF, Mexico

[2] Sanofi Aventis Mexico, Mexico City, DF, Mexico

[3] Natl Inst Cardiol Ignacio Chavez, Mexico City, DF, Mexico

[4] Inst Mexicano Seguro Social, Zona Poniente, Toluca, Mexico

[5] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico

来源：

VALUE IN HEALTH | 2007年 / 10卷 / 06期

关键词：

D O I：

10.1016/S1098-3015(10)64987-X

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A266 / A266

页数：1

共 50 条

[1] Pharmacoeconomic aspects of treatment of type 2 diabetes mellitus
Nedosugova, L. V.
DIABETES MELLITUS, 2008, 11 (02): : 76 - 79
[2] Repaglinide - A pharmacoeconomic review of its use in type 2 diabetes mellitus
Plosker, GL
Figgitt, DP
PHARMACOECONOMICS, 2004, 22 (06) : 389 - 411
[3] Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus
Rudakova, A. V.
DIABETES MELLITUS, 2011, 14 (03): : 111 - 112
[4] RepaglinideA Pharmacoeconomic Review of its Use in Type 2 Diabetes Mellitus
Greg L. Plosker
David P. Figgitt
PharmacoEconomics, 2004, 22 : 389 - 411
[5] Type 2 Diabetes Mellitus: A Pathophysiologic Perspective
Westman, Eric C.
FRONTIERS IN NUTRITION, 2021, 8
[6] Type 2 diabetes mellitus: a cardiovascular perspective
Varughese, GI
Tomson, J
Lip, GYH
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (07) : 798 - 816
[7] Pharmacoeconomic Analysis of Sitagliptin/Metformin for the Treatment of Type 2 Diabetes Mellitus: A Cost-Effectiveness Study
Rojas, Giovanni
Nunes, Altacilio
VALUE IN HEALTH REGIONAL ISSUES, 2021, 26 : 33 - 39
[8] Pharmacoeconomic analysis of efficiency of a combination of metformin -insulin(siofor) therapy in patients with type 2 diabetes mellitus
Demidova, I. Yu
Gorokhova, T., V
Belousov, Yu. B.
Belousov, D. Yu
DIABETES MELLITUS, 2009, 12 (02): : 63 - 66
[9] ECONOMIC BURDEN OF TYPE 2 DIABETES MELLITUS FOR MEXICO
Soto-Molina, H.
Diaz Martinez, J.
Ceballos, R.
VALUE IN HEALTH, 2015, 18 (07) : A863 - A864
[10] A pharmacoeconomic analysis of the use of an intensive strategy for treatment of patients with diabetes mellitus type 2 (DM T2)
Smirnova, OM
Komarova, VP
VALUE IN HEALTH, 2004, 7 (06) : 742 - 742

← 1 2 3 4 5 →